Literature DB >> 8350273

Effect of endothelin-3 on vasopressin release in vitro and water excretion in vivo in Long-Evans rats.

N F Rossi1.   

Abstract

1. The endothlins (ETs) are a family of homologous peptides originally isolated and purified from cultured porcine endothelial cells. Although initial studies focused on the ETs as potent vasoconstrictor substances, recent findings support a role for ET in vasopressin (AVP) secretion and action. We used cultured explants of the hypothalamo-neurohypophysial complex (HNC) to examine the effects of ET-3 on AVP release. 2. ET-3 produced a significant and concentration-dependent rise in AVP release from the explants of Long-Evans rats at 48 h, independent of medium osmolality. AVP release during two sequential control periods did not differ, and osmotically stimulated AVP release was comparable to that exhibited by HNC explants from Sprague-Dawley rats. ET-3 (1 nM) induced a 3-fold rise in AVP that was completely blocked by rabbit antiET serum, which did not alter basal AVP secretion. 3. Clearance experiments were performed in anaesthetized water-loaded rats given a non-pressor dose of ET-3 (0.40 nmol (kg body weight)-1 intravenously). The means of body weight, arterial blood pressure, plasma Na+ concentrations, and plasma osmolalities did not differ between the first and second periods nor among the groups. Despite no changes in renal plasma flow and inulin clearance, free water clearance significantly increased in the ET-treated group. This response could not be attributed to changes in osmolal clearances or Na+ reabsorption. The concurrent administration of antiET serum not only blocked this effect, but was associated with the free water clearance falling significantly below the pretreatment level. 4. Taken together, our in vivo and in vitro findings support the hypothesis that ET-3 stimulates AVP secretion. Furthermore, our data are consistent with the site of action of ET-3 residing within the blood-brain barrier, though an independent effect by a higher concentration of ET at neural loci outside the barrier cannot be totally excluded. Finally, the subpressor dose of ET-3 amplifies free water excretion independent of systemic and renal haemodynamics, Na+ excretion, osmolal clearance, or circulating AVP levels.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8350273      PMCID: PMC1175269          DOI: 10.1113/jphysiol.1993.sp019525

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  28 in total

1.  Cholinergic stimulation of vasopressin release from the rat hypothalamo-neurohypophyseal system.

Authors:  C D Sladek; K M Knigge
Journal:  Endocrinology       Date:  1977-08       Impact factor: 4.736

2.  Cardiovascular, renal, and endocrine responses to intravenous endothelin in conscious dogs.

Authors:  K L Goetz; B C Wang; J B Madwed; J L Zhu; R J Leadley
Journal:  Am J Physiol       Date:  1988-12

Review 3.  Disordered water metabolism: hyponatremia.

Authors:  N F Rossi; P Cadnapaphornchai
Journal:  Crit Care Clin       Date:  1987-10       Impact factor: 3.598

4.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

5.  Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action.

Authors:  M W MacCumber; C A Ross; B M Glaser; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

6.  Effect of endothelin-1 on release of arginine-vasopressin from perifused rat hypothalamus.

Authors:  M Shichiri; Y Hirata; K Kanno; K Ohta; T Emori; F Marumo
Journal:  Biochem Biophys Res Commun       Date:  1989-09-29       Impact factor: 3.575

7.  Binding sites for endothelin-1 in rat tissues: an autoradiographic study.

Authors:  C Koseki; M Imai; Y Hirata; M Yanagisawa; T Masaki
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

8.  Anti-calmodulin agents affect osmotic and angiotensin II-induced vasopressin release.

Authors:  N F Rossi; R W Schrier
Journal:  Am J Physiol       Date:  1989-04

9.  Effects of endothelin-3 on renal functions.

Authors:  Y Yamashita; T Yukimura; K Miura; M Okumura; K Yamamoto
Journal:  J Pharmacol Exp Ther       Date:  1991-12       Impact factor: 4.030

10.  Altered osmotic thresholds for vasopressin secretion and thirst in human pregnancy.

Authors:  J M Davison; E A Gilmore; J Dürr; G L Robertson; M D Lindheimer
Journal:  Am J Physiol       Date:  1984-01
View more
  4 in total

Review 1.  Physiology of endothelin and the kidney.

Authors:  Donald E Kohan; Edward W Inscho; Donald Wesson; David M Pollock
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

Review 2.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

3.  Opposing actions of endothelin-1 on glutamatergic transmission onto vasopressin and oxytocin neurons in the supraoptic nucleus.

Authors:  Aleksander R Zampronio; J Brent Kuzmiski; Clare M Florence; Sean J Mulligan; Quentin J Pittman
Journal:  J Neurosci       Date:  2010-12-15       Impact factor: 6.167

4.  Subfornical organ differentially modulates baroreflex function in normotensive and two-kidney, one-clip hypertensive rats.

Authors:  Maria Maliszewska-Scislo; Haiping Chen; Robert A Augustyniak; Dale Seth; Noreen F Rossi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-07-02       Impact factor: 3.619

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.